In Brazil, there is no procedure for querying prescription drug monitoring programs. The rule stipulates that products must be recorded in an electronic book system and this information is sent to the system controlled by Anvisa, called SNGPC (National System for the Management of Controlled Products). Currently, the system is suspended for adjustments.